How many studies have been conducted on Imipenem?

BiohacksAI has indexed 299 PubMed studies on Imipenem, including 19 randomized controlled trials (RCTs). 46% of studies involve human subjects.

What are the main research areas for Imipenem?

The primary research domains for Imipenem are 🫘 Kidney, 🧠 Focus & Attention, 😴 Sleep. This is based on analysis of 299 PubMed studies using the BiohacksAI evidence platform.

BETABiohacksAI is a research tool for informational purposes only. All outputs are computational hypothesis candidates — not confirmed mechanisms, not medical advice, and not a substitute for professional medical judgment. Independent experimental validation is always required.

Imipenem

a wide spectrum of antibacterial activity against gram-negative and gram-positive aerobic and anaerobic bacteria, including many multiresistant strains. It is stable to beta-lactamases. Clinical studies have demonstrated high efficacy in the treatment of infections of various body systems. Its effectiveness is enhanced when it is administered in combination with CILASTATIN, a renal dipeptidase inhibitor.

299+ PubMed studies analyzed · 19 RCTs · Evidence Score: 48.6

Research Domains

Imipenem has been studied across 10 research domains including 🫘 Kidney, 🧠 Focus & Attention, 😴 Sleep, 🔬 Oncology, 🫁 Liver & Detox. The primary research focus is 🫘 Kidney with 9% of studies addressing this area.

Loading evidence profile...

This evidence profile for Imipenem is generated deterministically from 299 PubMed-indexed studies. All data is corpus-verified with Merkle proofs. BiohacksAI does not provide medical advice. Always consult a healthcare professional before starting any supplement regimen.